 Proactive Investors Australia |
KarmelSonix appoints Viriathus to support OTC listing, to step up U.S. asthma …
Proactive Investors Australia KarmelSonix focuses on supplying innovative, non-invasive acoustic tools for disease management of asthma and related pulmonary disorders. The company's product offerings afford KarmelSonix a unique opportunity to adopt a business model that combines … |
View full post on asthma – Google News